The Zacks Analyst Blog Highlights Johnson & Johnson, Toyota Motor, Infosys, Novartis and Equinix
Johnson & Johnson, Toyota Motor, Infosys, Novartis and Equinix are part of the Zacks top Analyst Blog....…
145,450€
1,09%
Echtzeit-Aktienkurs Johnson & Johnson
Bid:
Ask:
Nachrichten zur Johnson & Johnson Aktie
Ready to Buy the Dip? Johnson & Johnson Stock Is a Smart Buy
Close to its 52-week low, this healthcare stalwart remains a good purchase....…
Johnson & Johnson stock falls Friday, still outperforms market
Johnson & Johnson stock falls Friday, still outperforms market...…
Top Stock Reports for Johnson & Johnson, Toyota Motor & Infosys
Todays Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Toyota Motor Corporation (TM)…
Johnson & Johnson Unusual Options Activity
read more...…
Johnson & Johnson stock underperforms Thursday when compared to competitors
Johnson & Johnson stock underperforms Thursday when compared to competitors...…
Johnson & Johnson stock outperforms market on strong trading day
Johnson & Johnson stock outperforms market on strong trading day...…
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…
Johnson & Johnson stock rises Tuesday, still underperforms market
Johnson & Johnson stock rises Tuesday, still underperforms market...…
Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains
Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains...…
Zacks Industry Outlook Highlights J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi
J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi have been highlighted in this Industry Outlook article....…
Johnson & Johnson, Kellogg, and 2 Other Spinoffs to Watch in 2023
Kellogg, Johnson & Johnson, Crane, and BorgWarner are planning to hive off a chunk of their businesses in 2023. What…
Johnson & Johnson stock falls Thursday, still outperforms market
Johnson & Johnson stock falls Thursday, still outperforms market...…
Johnson & Johnson stock falls Wednesday, underperforms market
Johnson & Johnson stock falls Wednesday, underperforms market...…
J&J consumer health spinoff Kenvue begins bond sale to fund separation - Bloomberg
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson stock outperforms market despite losses on the day
Johnson & Johnson stock outperforms market despite losses on the day...…
Protagonist Therapeutics Sees Positive Topline Results in JNJ-2113 Trial
Protagonist Therapeutics Sees Positive Topline Results in JNJ-2113 Trial...…
Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Johnson & Johnson (JNJ) closed at $155.56, marking a +1% move from the previous day....…
Johnson & Johnson stock rises Monday, outperforms market
Johnson & Johnson stock rises Monday, outperforms market...…
J&J Kenvue spinoff adds slew of banks to its initial public offering roster
Kenvue Inc., the consumer products spinoff from Johnson & Johnson JNJ, has grown the roster of banks underwriting its initial…
Johnson & Johnson stock rises Friday, still underperforms market
Johnson & Johnson stock rises Friday, still underperforms market...…
Johnson & Johnson stock underperforms Thursday when compared to competitors
Johnson & Johnson stock underperforms Thursday when compared to competitors...…
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…
Johnson & Johnson stock falls Wednesday, still outperforms market
Johnson & Johnson stock falls Wednesday, still outperforms market...…
Johnson & Johnson: Ersteinschätzung
New York (www.aktiencheck.de) - Rating-Update:
Vamil Divan, Analyst von Guggenheim Securities, startet die Coverage der Aktie von Johnson & Johnson (J&J)…
J&J initiated at neutral at Guggenheim on need for pharma, medtech growth visibility
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know
Johnson & Johnson (JNJ) closed the most recent trading day at $153.26, moving -1.52% from the previous trading session....…
Johnson & Johnson stock underperforms Tuesday when compared to competitors
Johnson & Johnson stock underperforms Tuesday when compared to competitors...…
Johnson & Johnson stock falls Monday, underperforms market
Johnson & Johnson stock falls Monday, underperforms market...…
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…
Johnson & Johnson stock falls Friday, underperforms market
Johnson & Johnson stock falls Friday, underperforms market...…
Buy the Dip in Johnson & Johnson and Its Near-3% Dividend Yield
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson wins EU nod for prostate cancer therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson stock outperforms competitors despite losses on the day
Johnson & Johnson stock outperforms competitors despite losses on the day...…
Johnson & Johnson (JNJ) Down 6.9% Since Last Earnings Report: Can It Rebound?
Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…
Johnson & Johnson (JNJ) Stock Moves -0.14%: What You Should Know
Johnson & Johnson (JNJ) closed the most recent trading day at $157.78, moving -0.14% from the previous trading session....…
J&J Agrees to Pay $9.9 Million to Resolve Kentucky Vaginal-Mesh ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Relative Strength Alert For Johnson & Johnson
But making Johnson & Johnson an even more interesting and timely stock to look at, is the fact that in…
Johnson & Johnson stock underperforms Tuesday when compared to competitors
Johnson & Johnson stock underperforms Tuesday when compared to competitors...…
UPDATE 1-J&J loses challenge to $302 mln judgment over pelvic mesh marketing
...(Adds statement from California)
By Brendan Pierson
Feb 21 (Reuters......…
J&J loses challenge to $302 million judgment over pelvic mesh marketing
...By Brendan Pierson
(Reuters) -The U.S. Supreme Court on Tuesday let......…
Johnson & Johnson fails in bid to overturn $302M vaginal-mesh award – Bloomberg
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
J&J Is Rejected by Supreme Court Over $302 Million Vaginal-Mesh ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Antiglaucoma Drugs Global Market Report 2023
NEW YORK, Feb. 20, 2023 /PRNewswire/ -- Major players in the antiglaucoma drugs market are Aerie Pharmaceuticals, Inc., Allergan, Novartis…
Gericht verpasst Johnson & Johnson Dämpfer um krebsverdächtiges Babypuder
NEW BRUNSWICK (dpa-AFX) - Der US-Pharma- und Konsumgüterkonzern Johnson & Johnson hat im Zusammenhang mit…
Johnson & Johnson verfehlt 2022 eigene Wachstumsziele
NEW BRUNSWICK (dpa-AFX) - Weniger verkaufte Covid-Impfungen und der starke Dollar haben den Pharma- und Konsumgüterkonzern…
Johnson & Johnson: Aussichtsreicher HIV-Impfstoff schützt nicht
BERLIN (dpa-AFX) - Ein besonders aussichtsreicher Impfstoffkandidat gegen die Immunschwächekrankheit Aids schützt nicht ausreichend vor einer…
Johnson&Johnson-Sparte Kenvue stellt Antrag auf Börsennotierung
Bangalore (Reuters) - Die Consumer-Health-Sparte mit rezeptfreien Medikamenten und anderen Gesundheitsprodukten des US-Pharmakonzerns Johnson & Johnson (J&J) hat einen Antrag…
Gesundheitskonzern Johnson & Jonson spürt Gegenwind durch starken Dollar
NEW BRUNSWICK (dpa-AFX) - Der Gegenwind durch den starken US-Dollar hat den Gesundheitskonzern Johnson & Johnson…
US-Gesundheitskonzern Johnson & Johnson senkt wegen Dollarstärke Prognose
NEW BRUNSWICK (dpa-AFX) - Der starke Dollar bremst den Gesundheitskonzern Johnson & Johnson . Für das…